-
1 Comment
BrightGene Bio-Medical Technology Co., Ltd is currently in a long term downtrend where the price is trading 17.1% below its 200 day moving average.
From a valuation standpoint, the stock is 128.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 22.0.
BrightGene Bio-Medical Technology Co., Ltd's total revenue rose by 44.9% to $275M since the same quarter in the previous year.
Its net income has increased by 1.8% to $48M since the same quarter in the previous year.
Based on the above factors, BrightGene Bio-Medical Technology Co., Ltd gets an overall score of 2/5.
| Sector | Healthcare |
|---|---|
| ISIN | CNE100003PR1 |
| Exchange | SHG |
| CurrencyCode | CNY |
| Industry | Biotechnology |
| Market Cap | 21B |
|---|---|
| Beta | 0.32 |
| PE Ratio | 148.0 |
| Target Price | 44.21 |
| Dividend Yield | None |
BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China. The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection. It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates. In addition, the company offers veterinary drugs. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688166.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
